
End to End of What, Exactly?
Every oncology tech vendor claims to be end-to-end. Most are not. Here is what that claim actually means, and what it should.
Insights on oncology innovation, AI in healthcare, and best practices from the Azra AI team.

Every oncology tech vendor claims to be end-to-end. Most are not. Here is what that claim actually means, and what it should.

The clinical case for enterprise oncology standardization is usually clear. The harder challenge is the organizational one. Here is a framework cancer service line executives have used to build alignment from the top down and the bottom up.

This month, we spotlight Jenny Cross, a Nurse Navigator at Nebraska Methodist Hospital's Incidental Lung Nodule Program, whose 15 years in oncology reflect the dedication and compassion at the heart of cancer care.

Not every health system knows it needs enterprise oncology standardization. Here are five signs your cancer program is ready for a different approach.

Most cancer service line leaders have the wrong definition of standardization. Here is what it actually looks like when it works.

Every major health system wants a cancer program that delivers consistent, coordinated care at every site. Most are falling short — and the reasons are structural, not personal.